Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hewa Artin"'
Autor:
Reza Tadayonnejad, Cole Citrenbaum, Thuc Doan P. Ngo, Juliana Corlier, Scott A. Wilke, Aaron Slan, Margaret G. Distler, Gil Hoftman, Adesewa E. Adelekun, Michael K. Leuchter, Ralph J. Koek, Nathaniel D. Ginder, David Krantz, Hewa Artin, Thomas Strouse, Ausaf A. Bari, Andrew F. Leuchter
Publikováno v:
Brain Stimulation, Vol 16, Iss 5, Pp 1374-1376 (2023)
Externí odkaz:
https://doaj.org/article/7b7fd456dec34c35961ff400131411be
Autor:
Hewa Artin, Sean Bentley, Eamonn Mehaffey, Fred X. Liu, Kevin Sojourner, Andrew W. Bismark, David Printz, Ellen E. Lee, Brian Martis, Sharon De Peralta, Dewleen G. Baker, Jyoti Mishra, Dhakshin Ramanathan
Publikováno v:
EClinicalMedicine, Vol 48, Iss , Pp 101439- (2022)
Summary: Background: (S)-ketamine is a glutamatergic drug with potent and rapid acting effects for the treatment of depression. Little is known about the effectiveness of intranasal (S)-ketamine for treating patients with comorbid depression and post
Externí odkaz:
https://doaj.org/article/242ecd618d914a6eae1532cfd7779b8a
Autor:
Sean Bentley, Hewa Artin, Eamonn Mehaffey, Fred Liu, Kevin Sojourner, Andrew Bismark, David Printz, Ellen E. Lee, Brian Martis, Sharon De Peralta, Dewleen G. Baker, Jyoti Mishra, Dhakshin Ramanathan
Publikováno v:
Pharmacotherapy, vol 42, iss 3
BackgroundRacemic (R,S)-ketamine is a glutamatergic drug with potent and rapid acting antidepressant effects. An intranasal formulation of (S)-ketamine was recently approved by the US Food and Drug Administration (FDA) to be used in individuals with
Publikováno v:
World Journal of Psychiatry
Depression is a common mental disorder and one of the leading causes of disability around the world. Monoaminergic antidepressants often take weeks to months to work and are not effective for all patients. This has led to a search for a better unders
Autor:
Hewa, Artin, Sean, Bentley, Eamonn, Mehaffey, Fred X, Liu, Kevin, Sojourner, Andrew W, Bismark, David, Printz, Ellen E, Lee, Brian, Martis, Sharon, De Peralta, Dewleen G, Baker, Jyoti, Mishra, Dhakshin, Ramanathan
Publikováno v:
EClinicalMedicine. 48
(We performed a retrospective case series analysis of clinical outcomes in 35 Veterans with co-morbid depression and PTSD who were treated with intranasal (During the induction phase of treatment there was an absolute reduction of 5.1 (SEM 0.7) on th
Autor:
Jack H. Owens, Murali Rao, Angelos Halaris, Edwin Meresh, Cara Joyce, Alvaro J.L. La Rosa, Steven Birch, Hewa Artin, David Daniels
Publikováno v:
Open Access Rheumatology: Research and Reviews. 11:103-109
Background: Fibromyalgia (FM) is a chronic medical condition characterized by widespread pain, sleep disturbance, and cognitive dysfunction. Sleep disorders are thought to play a prominent role in the etiology and symptomatic management of FM, specif
Autor:
Dhakshin S. Ramanathan, Hewa Artin, Sean Bentley, Fred X. Liu, David Printz, Jyoti Mishra, Sharon De Peralta, Brian Martis, Dewleen G. Baker, Kevin Sojourner, Andrew W. Bismark, Eamonn Mehaffey, Ellen E. Lee
Publikováno v:
SSRN Electronic Journal.
Objective: Ketamine is a glutamatergic drug with potent and rapid acting effects for the treatment of depression. Little is known about the effectiveness of intranasal (S)-ketamine for treating patients with comorbid depression and PTSD. Methods: We
Autor:
Edwin S, Meresh, Hewa, Artin, Cara, Joyce, Steven, Birch, David, Daniels, Jack H, Owens, Alvaro J, La Rosa, Murali S, Rao, Angelos, Halaris
Publikováno v:
Open Access Rheumatology : Research and Reviews
Background: Fibromyalgia (FM) is a chronic medical condition characterized by widespread pain, sleep disturbance, and cognitive dysfunction. Sleep disorders are thought to play a prominent role in the etiology and symptomatic management of FM, specif